- Home
- VKTX vs CYTK Comparison
VKTX vs CYTK Comparison
Compare VKTX & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- CYTK
- Stock Information
- Founded
- VKTX 2012
- CYTK 1997
- Country
- VKTX United States
- CYTK United States
- Employees
- VKTX N/A
- CYTK N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- CYTK Biotechnology: Pharmaceutical Preparations
- Sector
- VKTX Health Care
- CYTK Health Care
- Exchange
- VKTX Nasdaq
- CYTK Nasdaq
- Market Cap
- VKTX 7.2B
- CYTK 6.7B
- IPO Year
- VKTX 2015
- CYTK 2004
- Fundamental
- Price
- VKTX $49.58
- CYTK $50.22
- Analyst Decision
- VKTX Strong Buy
- CYTK Buy
- Analyst Count
- VKTX 10
- CYTK 16
- Target Price
- VKTX $109.80
- CYTK $83.67
- AVG Volume (30 Days)
- VKTX 6.8M
- CYTK 1.2M
- Earning Date
- VKTX 10-23-2024
- CYTK 11-06-2024
- Dividend Yield
- VKTX N/A
- CYTK N/A
- EPS Growth
- VKTX N/A
- CYTK N/A
- EPS
- VKTX N/A
- CYTK N/A
- Revenue
- VKTX N/A
- CYTK $3,219,000.00
- Revenue This Year
- VKTX N/A
- CYTK N/A
- Revenue Next Year
- VKTX N/A
- CYTK $911.39
- P/E Ratio
- VKTX N/A
- CYTK N/A
- Revenue Growth
- VKTX N/A
- CYTK N/A
- 52 Week Low
- VKTX $10.51
- CYTK $30.68
- 52 Week High
- VKTX $99.41
- CYTK $110.25
- Technical
- Relative Strength Index (RSI)
- VKTX 31.07
- CYTK 38.25
- Support Level
- VKTX $62.50
- CYTK $50.88
- Resistance Level
- VKTX $70.41
- CYTK $59.39
- Average True Range (ATR)
- VKTX 5.16
- CYTK 2.07
- MACD
- VKTX -2.29
- CYTK -0.04
- Stochastic Oscillator
- VKTX 1.99
- CYTK 3.78
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.